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Abstract 
Purpose: To determine the effect of allicin on Staphylococcus aureus cell wall peptidoglycans 
by the application of MALDI-TOF mass spectrometry on whole cells and to relate this to current 
knowledge of wall processing enzymes.   
Methodology: Two different S. aureus strains were grown for 48 hours after which period each 
culture was split into two, one part was then treated with sub-inhibitory levels of allicin while the 
other part left untreated as a control. After a further 24 hours whole cells were recovered and 
analysed by MALDI-TOF mass spectrometry.  
Results:  Changes in the mass spectra between the treated and untreated cells revealed 
fragmented peptidoglycans identified by mass calculation only in the treated cells. These 
peptidoglycan fragments where identified as the products of specific peptidoglycan hydrolases.   
Conclusions: Allicin is known to target cysteine thiol groups. These are absent in peptidoglycan 
hydrolases and we might had expected identical results in both of the treated and untreated cells.  
Peptidoglycan synthesis enzymes such as the Fem family of enzymes do contain cysteines. Fem 
enzymes A, B and X all have a conserved conformation of 99% of S. aureus strains in database 
and are therefore putative targets for allicin. Examination of FemA structure showed that 
cysteine102 is accessible from the surface. We propose that allicin has an inhibitory mechanism 
alongside others of targeting FemA and possibly other Fem enzymes by curtailing glycine 
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bridging and leading to fragmentation. This study provided an insight into yet another 
antimicrobial mechanism of allicin.  
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Introduction 
The rapid spread of antibiotic-resistant pathogens poses a serious threat to public health. Gram-
positive bacteria such as S. aureus are still giving concerns in the hospital environment and have 
become increasingly difficult to treat because of rapid development of resistant strains to common 
antibiotics. Penicillin resistant strains of S. aureus developed 4 years after the introduction of 
penicillin and have rapidly spread [1]. Similarly S. aureus strains resistant to methicillin (MRSA) 
developed 2 years after this drug was first introduced in Europe and are currently still recognized 
as a major problem in hospitals throughout the world [2].  
 
Novel effective agents ideally with known mechanism of actions are needed. Allicin 
(Diallythiosulphinate, also known as Thio-2-propene-1-sulphinic acid S-allyl ester) from Allium 
sativum has been shown to exhibit anti-microbial properties to a number of microbes including 
reference strains and clinical isolates of S. aureus. Cutler and Wilson showed allicin to be active 
against cultured strains of methicillin resistant clinical isolates of 49 S. aureus at a minimum 
inhibitory concentration (MIC) of 16 μgxml-1 and to totally inhibit growth at 32 μgxml-1 [3].  As 
for methicillin-resistant clinical isolates obtained from the Royal London and St. Bartholomew’s 
Hospitals, 30 were tested and 88% of those tested showed a minimum bactericidal concentration 
(MBC) of 128 μgxml-1 and were all killed at 256 μgxml-1. The biological activity of allicin comes 
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from a reaction with thiol groups of cysteines to form S-allylmercaptocysteine as demonstrated 
in many proteins [4-7]. This is further confirmed by the fact that the antibacterial effect of allicin 
is abolished by cysteine, glutathione and coenzyme A in S. aureus and E. coli [8]. 
 
The cell wall of Gram-positive bacteria consist of polymers of thick layers of peptidoglycans 
comprises of N-acetylglucosamine (GlcNAc)→β1,4 N-acetylmuramic (MurNAc) disaccharides. 
MurNAc is linked to L-alanine through a lactyl side chain that then forms further linkages to other 
stem peptides that cross links to stabilize the structure. In S. aureus the next amino acid in the 
stem peptide is D-isoglutamine followed by L-lysine then by D-alanine. This last L-lysine forms 
a connection with its ε-amino group to the first glycine in a pentaglycyl bridge with the last 
glycine connecting to a neighbouring tetrapeptide alanine carboxyl group. There are a number of 
additions to these peptidoglycan layers principally that of wall teichoic acid (WTA) and O-
acetylation.  
 
We report the application of Matrix assisted laser desorption-ionization–time of flight mass 
spectrometry (MALDI-TOF mass spectrometry) carried out so to allow components of the cell 
coat to be analysed following cell disruption and release through a laser impacting the cell surface 
[9]. This is particular useful for the examination of the ‘tough’ cell wall of Gram-positive bacteria 
and is ideal for the analysis of small and large molecular mass components at or in the cell surface. 
We apply this analysis to untreated and allicin treated S. aureus cells. Results are interpreted by 
accessing the vast amount of documented molecular information in protein Data bases on S. 
aureus strains.   
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Methods 
Allicin originally from Allicin International Limited (Half House, Military Road, Rye, East 
Sussex, UK) was kindly donated to us by Dr. Ron Cutler in a 5.0 mgxml-l solution in water. 
Allicin International had previously tested purity and confirmed concentration by HPLC.  Further 
allicin verification was achieved by us with MALDI-TOF mass spectrometry. Allicin although 
containing two allyl chains is soluble in water up to 5.0 mgxml-1. Allicin has been reported to be 
stable as measured by antibacterial activity towards S. aureus at 23oC in aqueous solution with a 
half-life of about 6.5 days, while in a 20% ethanol solution it has a biological half-life of about 
17.6 days and in 70% ethanol solution 8.7 days [10]. Allicin is unstable in hexane (half life of 8.8 
hours) and vegetable oil (half life 2.4 hours). Because of the stability and maintenance of activity 
in an aqueous extraction this is the recommended procedure and organic extraction is avoided 
[3].  
 
Bacteria Cultures 
S. aureus strains: oxford (NCTC 6571) and a clinical isolate strain were donated by Dr Ron Cutler 
originally obtained from the Royal London and St. Bartholomew’s Hospitals. These two strains 
were known to be inhibited by allicin. These two strains were grown as separate liquid cultures 
in Mueller-Hinton broth (Oxoid CM405) with gentle shaking at 37oC.  After 2 days of growth 
each culture was split into two and placed into two separate 50 ml centrifuge tubes. A final 
concentration of 63 μgxml-1 of allicin (sub-inhibitory levels) was added to one half of both 
cultures while the second half was left untreated. All four samples were incubated for a further 
24 hours with gentle shaking at 37oC. Whole cells were then recovered by gentle centrifugation 
at 300 x g for 6 minutes forming a loose pellet to avoid disruption to the bacteria surface. Cells 
were extensively washed twice in 0.15 moll-1 saline containing 0.02 moll-1 Tris-HCl pH 7.4 to 
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remove growth medium and excess allicin. In a third and final wash the Tris-HCl was omitted 
from the saline solution. 
 
MALDI-TOF Mass Spectrometry 
Samples were prepared by adding an equal volume of the matrix solution, 14% (w/v) α-cyano-4-
hydroxycinnamic acid (CHCA) in 70% (v/v) acetonitrile containing 0.015% (w/v) Trifluoroacetic 
acid (TFA) to all of the recovered whole cells. CHCA was chosen as it forms small homogenous 
crystals therefore surrounding cellular and cell wall components. Moreover as it is considered to 
be a ‘hard’ matrix it would impart a high energy captured from the laser excitation to cellular and 
cell coat components thus leading to disruption and desorption of these components.  A total of 
1.2 μl of all four samples were carefully placed into separate matrix pre-coated wells (1 μl of 
matrix previously dried down into the wells) in a MALDI plate. Triplicates were prepared for 
both treated and untreated samples and allowed to dry down at room temperature. Once dry, the 
MALDI plate was placed into an AXIMA (Shimadzu Scientific Instruments, Inc) CRF+ mass 
spectrometer equipped with a N2 laser (λ337nm) and configured for positive mode.  The laser 
power was set at 65 kV and the collected signal voltages were between that of 20 – 45 mV. After 
calibration using peptide standards (Sigma-Aldrich MALDI standards: P14R mass 1,532.8582 
Da and Bradykinin fragment 756.3997 Da) the samples are then analysed. At least 100 laser shots 
were collected around each well and averaged with the AXIMA Smooth Gauss program. Allicin 
was verified by the drying down of a small quantity of the original allicin solution into a matrix 
prepared well and subjected to MALDI-TOF mass spectrometry. All recorded spectra are 
displayed as relative abundance against mass/charge (m/z) in the range 1000 m/z to 12000 m/z..  
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Protein Resource Data Bank applications and Data Analysis.  
Protein sequences of peptidoglycan processing enzymes were accessed from the National Centre 
for Biotechnology Information (www.ncbi.nlm.nih.gov). All sequence alignments were carried 
out on line with the program BlastP using the Database: non-redundant protein sequences (nr) 
and by entering the query organism.  Full protein crystallographic structures were accessed from 
the Research Collaboration for Structural Bioinformation Protein Data Bank 
(www.rcsb.org/pdb/home/home.do) and detailed examination of the structure was carried out on 
line using the NGL 3D Viewer application [11,12].  If full protein structures were not yet 
available in the RCSB Data Bank then cysteine positions within a protein sequence are analysed 
on line by accessing the protein resource of UniProtKB that is available in ExPASy 
Bioinformatics Resource Portal (www.expasy.org).  
 
In interpreting the results the term ∆y is defined as a single difference (in units of m/z) between a 
calculated mass from the chemical composition and an experimentally determined mass 
measurement or between two experimental mass measurements. A relative percent error was 
calculated as 100 x (∆y / calculated value of m/z).  The term │∆│y is a set of all absolute 
differences in a Data set, for example a Data set might contain all the absolute values of ∆y for 
one cell strain within a spectral range. Correlation coefficients (r), means and standard deviations 
(SD) were then calculated from all the Data within │∆│y by using Microsoft Excel.   
 
Results 
Verification of Allicin. 
MALDI-TOF mass spectra of allicin is presented in Fig. 1 and demonstrates that on drying down 
in the matrix coated wells highly concentrated allicin aggregates are formed.  No allicin mass 
peaks were found at around 162 m/z however between every consecutive aggregate peak there 
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was a mean difference of 162.17 m/z and this agrees well with the literature values of allicin 
(162.265 Da). Each peak has been assigned as an allicin aggregate plus trifluoroacetic acid (TFA-
) that was present in the matrix and confirmed with the formula [n(162.17)/2 + (TFA-)/2]2+  with 
values of n from 8 to 22 (in steps of 2) and 113.02 Da for TFA-. This gave an overall mean with 
the Data set │∆│y between all the calculated and the recorded values of 0.11 m/z with a SD of 
0.033 m/z. No other contaminant appeared too co-precipitated with the aggregates supporting the 
purity of the allicin.  
 
Comparison of treated to untreated cells. 
MALDI-TOF mass spectra showed a clear a difference between allicin treated S. aureus strains 
(Fig. 2 traces iv to vi) when compared with control untreated strains (Fig. 2 traces i to iii) in the 
mass range 1100 m/z – 2000 m/z for both of the two strains. In the oxford strain Fig. 2(a), there 
are also differences in the mass range 2000 m/z to 10000 m/z while in the cell strain Fig. 2(b), 
some similarity in the mass profile remains. This is a reflection of the fact that MALDI-tof 
profiles belong to two different strains attained from different biological sources (13).  
 
A total of 18 major peaks with an average spacing of ~44 m/z were identified in the expanded 
view of the mass range 1100 m/z – 2000 m/z for both treated cell strains (Fig. 3). Between each 
peak ~18 minor peaks (~30 – 50% the intensity of the larger peaks) are present with an average 
spacing of ~44 m/z and shifted up from the larger peak by 15 – 16 m/z. These minor peaks also 
have their own satellite peaks. As these peaks are not found in the untreated cells we can exclude 
any extraneous attachment of agents arising from the culture medium or from a Matrix-induced 
fragmentation process or by pulse source decay (PSD).  
 
8 
 
A similar profile of peaks have been previously reported by MALDI-TOF spectrometry of 
different ratios and degrees of polymerisation (DP) of (GlcN)n and (GlcNAc)m and with chitin 
oligosaccharides (sodium and potassium adducts) with the majority of peaks in the range between 
600 m/z – 3000 m/z [14,15].  Examination of our multiple peaks in the 1150 m/z – 2000 m/z 
region in the allicin treated cells showed a similar pattern, however our peaks did not extend 
much beyond 2000 m/z. The highest peaks are likely to arise from sodium adducts (+23) of 
saccharides as our cells were prepared from saline and these being one of the most commonly 
detected in MALDI mass spectrometry of saccharides. Boneca [16] obtained spectra for 
oligosaccharides extracted from S. aureus however, their results were obtained by PSD on a 3-
aminoquinoline derivative (sodium adducts) rather than on cells directly. Therefore are not likely 
to reveal as much information on the processing and degradation of the cell wall compared to 
whole cell analysis. Our peaks arise from smaller oligosaccharide fragments from possible 
digestion of peptidoglycans or from fragmentation of the PIA or other cellular oligosaccharides 
but directly from whole bacteria unmodified samples and thus highly representative of the live 
cells state. These fragments were found only in the allicin treated cells after extensive washing 
suggesting that they must remain buried under or in the cell coat during growth and only released 
when undergoing MALDI-TOF spectrometry.    
 
Gram-positive bacteria may be O-acetylated (OAc) at position C6 on MurNAc by one of the key 
cytoplasmic membrane enzyme O-acetyltransferase OatA [17, 18]. The spacing between our 
peaks is on average 44 m/z which can be explained by the degree of O-acetylation that may occur 
for Bacteria peptidoglycans. Although we would expect the spacing’s to be 42 m/z the difference 
may reflect additional chemistry with the matrix. The most common reduction mechanism would 
be of a hydride reaction which is unlikely to take place in this instance as a strong hydride donor 
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is absent in our samples.  We therefore propose the existence of two other possible reactions 
which could take place within the matrix: 
i. Single electron stepwise reactions  
 
 R - O - CO - CH3  +  e-    →   [R - O - CeO−- CH3 ]  +   H+    →    [R - O - CeOH - CH3 ]  +  e-  → 
 [R - O - C−OH - CH3 ]    +   H+    →   R - O - CHOH - CH3       
                                                                                             
 ii. Enol tautomer reactions 
 
 R - O - CO - CH3       
              ↕                                                                      
 [R- O - COH = CH2   ↔   R - O+= COH - C−H2 ]     +     H+   +  2e-    →   [R - O - C−OH - CH3 ]      +   H+     →  
 R - O - CHOH - CH3       
 
The single electron stepwise reaction requires a strong electron donator and could be facilitated 
by the production of free electron and protons which are passed on to the substrate following 
laser ionization of the matrix [9].  Secondly although esters are harder to reduce then aldehydes 
or ketones as they exist principally in an oxygen-bonded ketone, the enol tautomer is able to 
undertake an acid-catalysed reaction as the transient double bonded central carbanion is 
nucleophilic and is reactive to electrophiles such as the cationic H+. Again we propose that this 
reaction may be aided by the laser ionization of the density packed matrix freeing up electrons 
and protons and passed on to the tautomer. Whichever reaction may take place a hemiacetal is 
rapidly generated. The solid phase of the matrix restricts movement of substrates and curtails 
any further addition reactions. 
 
Assignments of fragments from peptidoglycans 
To identify whether these fragments have arisen from the peptidoglycan layers it was necessary 
to examine peptidoglycan processing enzyme specificities as well as their products and 
susceptibility, if any, to allicin. Product assignment was achieved by the calculation of expected 
mass from peptidoglycan fragments. The value of 42.02 m/z was assigned to the N-acetyl group 
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for the non O-acetylated parent compound. Any additional O-acetylation carries a value of 44.02 
m/z which is consistent with the near constant differences in most of the assigned masses.  If 
differences between the calculated and measured mass in some of the assignments are 
considerably different than expected for mass spectra this might be attributed to some underlining 
peaks, drifting of the standardization or baseline variation. We therefore disregarded an 
assignment with differences greater than +/-1.5 m/z (average relative error of 0.10%) if found in 
both of the S. aureus strains.  
 
Under normal circumstances the peptidoglycan layers in the cell wall undergoes digestion by 
hydrolases during septum cleavage, in the formation of pores in the cell wall and the releasing of 
turnover products during cell growth as well as autolysis when under shock conditions. There are 
several enzymes responsible for this hydrolysis [18]. One of the key enzymes is the peptidoglycan 
aminohydrolase that of N-acetylmuramoyl-L-alanine amidase. This enzyme cleaves the bonds 
between that of N-acetylmuramoyl→L-alanine and is located on the outer side of the cytoplasmic 
membrane and protruding into the narrow periplasmic space.  Given the vast amount of 
information of allicin targeting cysteines thiol groups in many enzymes we undertook a search of 
the NCBI protein sequence Data Bank with the BlastP alignment program and choosing query 
proteins from S. aureus (Table 1).  No cysteines likely to interfere with enzyme activity were 
found. Thus we propose that this enzyme is still active and able to cleave the stem peptide from 
the polysaccharide layers.  
 
The exolytic transglycosylases such as the soluble lytic transglycosylases, hydrolyze β-1,4 
glycosidic bonds between N-acetylmuramic acid→N-acetylglucosamine and generally located in 
the narrow periplasmic space. This enzyme generates an anhMurNAc terminal glycan. The lytic 
transglycosylases are inhibited by O-acetylation on MurNAc thus anhMurNAc(OAc) is not found 
11 
 
[20]. Given the mass range of between 1000 m/z to 2000 m/z, we calculated the position 
(assuming a charge of +1 ) of peaks in a mass spectra by summing the masses and taking into 
account  loss of water as:  
                       (MurNAc GlcNAc)n (OAc)y anhMurNAc   +   23  (for Na
+ )   
Where n is number of disaccharides, y is total number of (OAc)y groups.  
Five corresponding masses (Table 2) that might be attributed to the enzyme products were found 
in our mass spectra in the mass range 1255 m/z to 1432 m/z with the number of disaccharides (n) 
of 2. Unfortunately no S. aureus soluble lytic transglycosylases (SLT’s) have been sequenced. 
However other Bacillales and Lactobacillales  SLT’s  enzyme sequences or domains have been 
sequenced and in Table 1 we present a survey of cysteines in fourteen SLT’s that are to be found 
in the UniProtKB Data bank (several strains have multiple entries and we have avoided 
reproducing these in our list). There were no cysteines found in any of these SLT domains. 
Although this is not a conclusive survey it is indicative that S. aureus might also be free of any 
cysteines in the SLT domain, explaining the recording of these cleavage products.  
 
Additional hydrolysis occurs with endo-β-N-Acetylglucosaminidase [16]. This enzyme will 
hydrolyse bonds between N-acetylglucosamine→N-acetylmuramic acid. We calculated the 
position (assuming a charge of +1) of the peaks in this region: 
                    MurNAc (GlcNAc MurNAc)n GlcNAc (OAc)y     +   23   
Table 2 presents some mass fragments that could be attributed to the enzyme products in the mass 
range 1475 m/z to 1741 m/z with the number of disaccharides (n) of two. A BlastP alignment of 
this enzyme revealed that there is no cysteine residues found in any of 71 matched enzymes 
entries (Table 1). 
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In the ranges 1387 m/z to 1432 m/z and 1651 m/z to 1741 m/z an unexpected addition of O-acetyl 
groups was needed to explain these assignments. We referred to this as Epi-acetylation. These 
results do suggest that some GlcNAc in addition to MurNAc are O-acetylated which has not been 
previously reported in Staphylococcus strains. As O-acetylation inhibits binding to some of the 
hydrolases discussed above, this further O-acetylation would occur after fragmentation of 
peptidoglycans. These shorter fragments are free from any rigid constraint within the 
peptidoglycan layer where they were previously attached and are now occupying the narrow 
periplasmic space thus coming in contact with the protruding catalytic domain of OatA. An 
increased flexibility of these fragments is achieved by the cleaving of the lactyl-alanine bond 
allowing rotation of the lactyl group on MurNAc with this lactyl side chain now able to take up 
different conformations as well as any rotational flexibility around the disaccharide β1-4 bond 
and presumably different spatial orientation of these smaller fragments. This could reduce any 
steric hindrance so the C6 hydroxyl of GlcNAc that may now enter the substrate binding site of 
OatA. Moreover these shorter fragments would become entangled in this narrow periplasmic 
space and this would explain why these fragments are only released on undergoing MALDI 
spectrometry and while not in the culture medium. Interestingly Sharif et al reported a partial 
thickness of the cross and outer cell wall at the septum as measured by TEM in Fem-deleted 
mutant S. aureus cells [21]. They suggested that this was likely formed by the accumulation of 
immature peptidoglycans in these Fem-deleted mutant cells. This agrees with our findings of 
peptidoglycan fragmentation.   
 
As O-acetylation is dependent on the enzyme OatA, the inhibitory effect of allicin on this enzyme 
was explored. The enzyme is separated into two domains the N-terminal domain contains 11 
closely packed transmembrane helices and two cysteines at positions 96 and 220 [22]. There are 
no transmembrane helices or cysteines found in the C-terminal domain. The C-terminal domain 
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protrudes out from the cytoplasm membrane into the narrow periplasmic space and carries the 
residues for a serine esterase activity. As these two domains are well separated it does place a 
distance from the activity region of the enzyme to those cysteines present in the N-terminal 
domain. Finally a BlastP run matched up >100 other S. aureus OatA entries (Table 1) with these 
two cysteines in the identical positions confirming a conserved conformation in these enzymes.     
 
Although we have not been able to assign all of the mass spectra to oligosaccharides (fragmented 
or not) it is clear there are consistent differences between the spectra of allicin treated and 
untreated bacteria. Masses in the range between 2000 m/z – 10000 m/z are due to the presence of 
longer polymers, or other cellular components. Significantly the relative abundance of the 
majority of the mass peaks in the treated cells compared to the untreated cells has decreased in 
both cell strains as expected. This is particularly evident in the regions of 4200 m/z – 4400 m/z 
and that of ~6400 m/z and in the oxford strain at ~6800 m/z.  Although loosely held surface 
polymers at the higher mass peaks might have been loss through the washing procedure the lack 
of such a loss on the control untreated cells suggests it is not.  In addition in the treated oxford 
cell line some peaks showed increased intensity, in particular those at around 4823 m/z and 9529 
m/z suggesting desorption of polymers of increased lengths or of new cellular components. These 
differences occurred consistently in all three independent prepared biological replicates 
confirming that they are representative of changes in the cell themselves.  
 
Discussion 
The analysis of the results showed consistency with previous reports. DP was calculated by 
adding to the lengths of the fragments found in the ranges 1250 m/z – 1432 m/z to the the GlcNAc 
end of those cleaved in the range 1475 m/z – 1740 m/z and proposes a minimal degree of 
polymerisation of 5 - 6 disaccharides with a loss of one GlcNAc to form a anhMurNAc terminal 
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end. This is in agreement with Boneca et al. who identified 3 - 10 disaccharides in S. aureus with 
an average of 5 - 6 and numbers of greater than 11 being present in low abundances [16]. 
Similarly, Dmitriev et al. derived by computer simulation the numbers of disaccharides in a 
peptidoglycan strand in E. coli [23].  They presented slightly higher results of between 4 - 30 
disaccharides in numbers and peaking at 8 - 11 disaccharide units and falling off rapidly after 
this. As oligosaccharide minimal binding sites for hydrolases vary between 3 and 6 [19] with 
hydrolysis falling off rapidly after 5 – 6 oligosaccharides. It is therefore not surprising that we 
only obtained cleaved units of 5 to 6 oligosaccharides in length. 
 
We suggest that peptidoglycan fragmentation shown during allicin treatment is caused by the 
action of cysteine-free hydrolases. As allicin is unable to inhibit such hydrolases then is it likely 
to facilitate activation and an accessibility of hydrolases to peptidoglycans. Because of its small 
size (162 Da) allicin can easily pass though the peptidoglycan layer which is between 20 – 100 
nm in thickness with pores ranging in size between 5 – 50 nm and is readily permeable through 
cell membranes [24-26].  Cell wall processing enzymes are therefore some of the first to come in 
contact with allicin. We propose that allicin is targeting some of the cell wall synthesis enzymes 
leading to a weakening of the lower peptidoglycan layer and leading to a fragmentation process 
while the cells are still in the culture medium. This explanation is supported by the fact that the 
fragmentation is not found in the untreated control cells even though we might expect that some 
hydrolases could still be activated or are already active in these control cells. To explore this 
possibility, the presence of cysteine free thiols groups and their location in wall synthesis 
enzymes was investigated.  
 
The peptidoglycan synthesis pathway in S. aureus has been well documented with the final 
stages of synthesis being that of: 
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Phospho-N-acetylmuramoyl-pentapeptide-transferase (MraY)  →    Lipid I  intermediate  → 
Undecaprenyldiphospho-muramoylpentapeptide-β-N-acetylglucosaminyltransferase (MurG)      
→ Lipid II intermediate  →   FemX  →  FemA   →  FemB   
→ (translocation to outer membrane)  →   Transglycosylases   →  Transpeptidases. 
 
Most importantly FemX and FemA are critical for the building of the pentaglycyl bridge with 
FemX adding the first glycine to the lipid II intermediate followed by FemA adding two 
glycine’s then by FemB adding the final two glycine’s. The crystal structure and the protein 
sequence of FemA from S. aureus have been determined [27]. Sequence Data has been deposited 
in both the RCSB protein Data Bank and the NCBL Data Bank (Table 1) and shown to contain 
two cysteine residues 56 and 102. A BlastP was run of this entry against all S. aureus (including 
methicillin resistant) entries and found these two conserved cysteine residues in >100 matching 
enzymes entries. The enzyme structure of FemA has a large globular domain with these two 
cysteines approximately 12.6 Å apart within the subdomain that of 1A and are too far apart to 
form a disulphide bridge and therefore presenting free thiol groups. The protein feature view in 
1LRZ shows residue 56 is in an ordered hydrophobic β strand region while residue 102 is in an 
ordered hydrophilic β turn region. Examination of the crystal structure revealed cysteine 102 is 
accessible through a cavity of approximate dimensions 6.8 Å x 4.5 Å wide at the protein surface 
with this cysteine at the floor of this cavity. As allicin is approximately the size of an apolar 
amino acid and on folding through hydrophobic interaction of the two allyl chains it could 
potentially enter or partial enter into this cavity and causing a disruption to the protein 
conformation.  
 
In FemB two cysteine residues are found in the first 100 matching enzyme entries. The full 
sequence alignment of FemA and FemB suggested that there is some similarity in these proteins 
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with 39% sequence identity, however only 1 cysteine matched up that of residue 102 [27]. The 
other residue 351 is aligned to an ordered α helix region of FemA. By measuring the distance 
from residue 353 which in FemA is an alanine (note. sequence numbering is increased by 2 for 
this cysteine position in 1LRZ) to cysteine 102 it is approximately 37.5 Å away and if both were 
now cysteines they could not form a disulphide bridge. Both of these cysteines will thus present 
free thiol groups. Interestingly this residue 102 is the cysteine that is accessible in FemA while 
residue 353 is closer to the L-shaped peptide binding pocket as well as to the protein outer surface. 
However it is most likely there are small differences in these two protein conformations so as to 
compare these two enzymes a full crystal structure of FemB would be required.  In FemX only 
one cysteine residue 70 is found in >100 matching enzymes entries. The full sequence alignment 
of FemA with FemX again suggested some similarity (26% sequence identity) [27]. The Fem X 
cysteine did not match up with any cysteines in FemA. The position of cysteine 70 is found to be 
in an ordered β strand region of FemA. By superimposing onto the position of phenylalanine 70 
in FemA it was found to lay in subdomain 1A and would have been close to position 102 which 
in FemX is now an alanine. However here again FemX might have a different conformation to 
FemA and we are not able to comment on the cysteine accessibility however this single cysteine 
must present a free thiol group.   
Sharif et al [21] reported peptidoglycan fragmentation in S. aureus with Fem-deleted mutants 
also containing truncated pentaglycine bridging. Specifically with FemX-deleted mutants glycine 
bridging was absent. While in FemA-deleted mutants they found those with a single bridging 
glycine, cross-linking was decreased by ~20% leading to a high concentration of open N-terminus 
monoglycyl segments. Recently Kim et al [28] reported the architecture of peptidoglycans in wild 
type S. aureus and favoured that the peptidoglycan chains forms a vertical scaffold type model 
[23] perpendicular to the membrane with parallel orientation of the stem peptides. Kim suggested 
this is formed as the average number of disaccharide units is only 6 (also refer to our results 
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above) with the numbers of glycine’s in the bridge being key factors in determining the types of 
different peptidoglycan architectures. Moreover they concluded there would be stem peptide 
‘crowding’ when forming short bridges and presumably open gap segments between those stem 
peptides when a bridge is not formed. Applying this same reasoning to the proposed inactivation 
of FemA by allicin and a possible inactivation of other Fem enzymes, we should therefore expect 
to find open gap segments between stem peptides and an accumulation of immature 
peptidoglycans. 
 
Finally we examined if any other peptidoglycan enzymes in S. aureus that might be affected by 
allicin and completed a search on key peptidoglycan enzymes in this later stage of synthesis. 
One cysteine residue was found in Phospho-N-acetylmuramoyl-pentapeptide-transferase 
(MraY) and again a BlastP run revealed the presence of one cysteine residue in all 80 matching 
enzymes. This cysteine is found to be in a long hydrophobic sequence and predicted using the 
resource UniProtKB with accession number entry Q2FZ93 to be in a transmembrane helix and 
buried within the cell membrane and therefore less accessible. No cysteine residues were found 
in Undecaprenyldiphospho-muramoylpentapeptide-β-N-acetylglucosaminyltransferase (MurG) 
or any of other 100 matching entries and with Transpeptidases (three PBP’s).  Finally the 
structure of a S. aureus Transglycosylase is deposited in the RCSB protein data base under 
3VMQ. Running the sequence in BlastP revealed at least 23 excellent matches in which none of 
these contained cysteine. All these searches are summarized in Table 1.  
 
 Many of the enzymes explored that are involved in cleavage of peptidoglycans, do not have 
cysteines and therefore unlikely to be a target for allicin. The fragments identified here appear 
to be the products of some of the enzymes discussed. Daniels et al proposed there is a general 
exclusion of cysteines and disulphide bond formation in Firmicutes such as S. aureus [28]. This 
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agrees with the findings of these wall processing enzymes and in particular the hydrolases. 
Although we could not absolutely connect the effect of allicin with the peptidoglycan synthesis 
enzymes discussed above, these synthesis enzymes are likely to be affected as some do contain 
free cysteine thiol groups. The disruption of these peptidoglycan synthesis enzymes that contain 
free cysteines would potentially lead to a halting of any new or the ideal peptidoglycan structure. 
The most likely candidates as a putative targets for allicin are those free cysteines (and thus 
presenting thiol groups) that are found in the S. aureus FemXAB protein family of enzymes thus 
disrupting the assembling of the pentaglycine bridge formation. Furthermore, we are confident 
that these enzymes would be targets in other S. aureus strains as high identity matches (>99%) 
for the same Fem enzyme (FemA, B or X) suggest a conserved protein conformation with an 
identical arrangement of cysteines. This would also explain the wide inhibitory effect of allicin 
in S. aureus strains.       
 
Taken together our results not only confirm that allicin is active against Gram-positive bacteria 
but indicate the existence of yet another mechanism of action.  Allicin targets Fem enzymes 
causing gaps in the lower cell wall and facilitates hydrolases access to and fragmentation of 
peptidoglycans. Allicin ability to affect the cell wall makes it an ideal combination treatment 
with alcohol containing bactericides as it is likely to have a synergistic action on treatments as 
well as reducing the risk of a spread of antibiotic resistance.     
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Table 1.  Cysteines in Peptidoglycan Processing Enzymes:  Staphylococcus aureus    
                 and SLTases in Firmicutes.               
 
 
Enzyme                                                                              Query*       Matches       Cover        Identities     Cysteines            
                                                                                                                                                                                                                      
N-Acetylmuramoyl-L-Alanine Amidase                    EWN33417          100         96-100%      99-100%           0                                                                                                                                                    
N-Acetylmuramoyl-L-Alanine Amidase                 AID38810            100         98-100%      96-100%           
(Amidase region (181 – 362) and includes the     
active site of this enzyme ).     
 
Soluble Lytic Transglycosylase     (UniProtKB).     common  Firmicutes
†
                                              0                                                  
                                                                    
Peptidoglycan endo-β-N-Acetylglucosaminidase     SAZ48439            71         98-100%     99-100%            0                                                                                                                                                                                                                                                                                                                                                    
 
 
 
 
Fem A                                                                               BAU34893         >100          100%        99-100%            2                                                                                                                                                                                                                                                                                                                                                                                         
Fem A        (RCSB)                                                        1LRZ                    self                                                       
 
Fem B                                                                                                    ADD85346        >100          100%         97-100%           2 
  
Fem X                                                                                                   ADD85351         >100          100%         99-100%           1 
 
MraY       (UniProtKB)                                                  Q2FZ93                 self                                                      1                                                                                                                                                                                                                          
MraY                                                                                                    BBA23731             80           100%         98-100%               
 
MurG                                                                         BAU34936         >100          100%        99-100%          0 
  
Peptidoglycan Transpeptidase.                                     CEH26378         > 100          100%         99- 100%          0 
(with region of  PBP 2 and  FtsI ) 
D,D-Transpeptidase matches      (UniProtKB)         A0A0E0VN59        34         100%         96-100%          0 
(identity match  of  >99% with region of 
S. aureus PBP 1 and  FtsI)    
PBP 2a (mrsa) (with FtsI region)                                 AKE50921        > 100           100%         99-100%           0    
PBP 3  (99% match with PBP 2)                               ANW82086      > 100           100%         99-100%          0 
     
 Peptidoglycan Glycosyltransferase      (RCSB)         3VMQ                   self                                                      0                                                                                                                                                                                        
 Peptidoglycan Glycosyltransferase.                            EFC07480               23           100%        99-100%    
             
    
 OatA                                                                                 BAX76438         >100           100%        99-100%            2 
  
* This is the NCBL accession query code (another DATA base). If sequences have shown to overlap, a partial 
sequence or has a low identity match a check has been made that those matched sequences do not contain cysteine. 
A few of the matches were with Staphylococcus multispecies.  
† Firmicutes surveyed are Bacillus.strains:  subtills (L8AQA9), cereus (A0A1Y6AXS), anthracis (D8H8F5), 
thuringiensis (A0A1C4C8S3),  megaterium (A0A0H4R7E0),  mycoides (A0A1G4EI40),  cytotoxicus 
(A0A1D3QNU2); Halobacillus.karajensis (A0A024P953),  Listeria.monocytogenes (A0A0E0UTJ9); 
Lactobacillales/Streptococcus strains:  pneumonia (A0A0Y0B8K7), anginosus ( F5U3V7), suis (A4VUN1);  
lactis (A0A0A7SYA5), plantarum  (A0A165VKK5). 
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Table 2  Putative (best fit) of Oligosaccharide Fragments.     Mass range 1255mz -1741m/z.  
               Sodium adducts (major peaks only).   
 
                                                                            Calculated m/z*     oxford       102         ∆oxf      ∆102      ∆oxf       ∆1     oxford      102 
                                                                             A                 B
†
           m/z             m/z           A          A           B         B     % relative errors    
           
(MurNAcGlcNAc)2 anhMurNAc†                  1255.27    1257.27      1255.27     1255.93        0       -0.66      2.00     1.34       0.000     -0.052                  
(MurNAcGlcNAc)2 (OAc) anhMurNAc         1297.29    1299.29      1299.30      1299.90    -2.01    -2.61     -0.01    -0.61    - 0.001     -0.047 
(MurNAcGlcNAc)2 (OAc)2 anhMurNAc       1339.31     1343.39      1343.48     1343.80    -4.17    -4.49     -0.09    -0.41     -0.007      -0.031 
 
 Epi-acetylation fragments 
(MurNAcGlcNAc)2 (OAc)3 anhMurNAc       1383.33     1387.33      1387.33     1387.84     -4.00    -4.51      0.00    - 0.51       0.000    -0.037 
(MurNAcGlcNAc)2 (OAc)4 anhMurNAc       1425.35     1431.35      1431.33     1431.82     -5.98    -6.47      0.02    - 0.47       0.001    -0.033 
 
MurNAc(GlcNAcMurNAc)2GlcNAc†             1476.53    1478.53     1475.33     1475.84        1.20     0.69      3.20       2.69      0.081     0.047                 
MurNAc(GlcNAcMurNAc)2GlcNAc (OAc)   1518. 55    1520.55    1519.44      1519.91      -0.89    -1.36       1.11      0.64      0.073     0.042                    
MurNAc(GlcNAcMurNAc)2GlcNAc (OAc)2  1560.57    1564.57     1563.46      1563.93      -2.89    -3.36      1.11      0.64       0.071     0.041 
MurNAc(GlcNAcMurNAc)2GlcNAc (OAc)3  1602.59    1608.59     1607.59      1608.01      -5.00    -5.42      1.00      0.58       0.062     0.036  
 
 Epi-acetylation fragments 
MurNAc(GlcNAcMurNAc)2GlcNAc (OAc)4    1644.61     1652.61     1651.72     1652.09     -7.11     -7.48      0.95      0.52       0.057     0.031 
MurNAc(GlcNAcMurNAc)2GlcNAc (OAc)5    1686.63     1696.63     1695.54     1696.06     -8.91     -9.43      1.09      0.57       0.064     0.033 
MurNAc(GlcNAcMurNAc)2GlcNAc (OAc)6    1728.65     1740.65     1739.36     1740.02   -10.71   -11.37      1.29      0.63       0.074     0.036 
                                                                                                                                                                                                                         
   
*   Masses in Daltons are taken as:  GlcNAc  203.24 (-H2O),  MurNAc  293.27 (+H2O),  anhMurNAc  275.25 
(+H2O),  GlcN  179. 17 (+H2O), OAc  42.02 (-H2O).   
Example calculation for  MurNAc(GlcNAcMurNAc)2GlcNAc:      293.27 – 18 +( 203.24 + 293.27) – 18 + (203.24 
+ 293.27) + 203.24 + 23  =  1476.53  m/z.   
† 
 Column A calculated mass, column B calculated mass increased by 2.0  m/z, refer to mass increase for carbonyl 
reduction (O-acetyl only) in text. Fragments marked † are calculated from values in column A (thus not increased 
by 2.0  m/z) these may act as internal standards.  
Correlation coefficients  r  = 0.999 is recorded for │∆│between both sets of experimental  results and for the 
│∆│calculated  v  for oxford and  the  │∆│calculated  v 102  experimental results.  
Mean  +  SD for all results:  │∆│both measured experimental  0.50 + 0.10  m/z  and  
calculated  v  experimental   │∆│oxford   0.65 + 0.54  m/z,   │∆│102 0.58 + 0.08 .m/z 
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FIGURE LEGENDS  
 
Figure 1. MALDI spectrum recorded of pure allicin. Allicin forms progressive aggregates when drying 
down in the matrix prepared wells. This is most likely due to the hydrophobic nature of the folded allyl 
chains.  The differences in the 5 peaks from 1029.39 m/z to 1840.27 m/z  are:  162.18; 162.17; 162.16; 
162.18; 162.18.  Mean  +  SD  =  162.17 + 0.009  m/z.  This demonstrates the consistency throughout this 
region. 
 
Figure 2.  MALDI mass spectra recorded as in methods. (a)  is the Staphylococcus aureus oxford strain, (b)  
is the 102 strain.  In both of the mass spectra the top three spectra show those cells that have been treated 
with 63 μgxml-1 of allicin for 24 hour while the bottom three spectra are the untreated controls.   
 
Figure 3. MALDI  mass spectra. Expanded region 1100m/z – 2000  m/z of the treated two strains: top trace 
is oxford and bottom  trace is 102. The values of {r} are a measure of the mass resolution. 
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